Pluvicto 1 000 MBq/mL solution for injection/infusion
*Company:
Novartis Ireland LimitedStatus:
NewLegal Category:
Product subject to restricted prescription (C)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company

Updated on 29 April 2025
File name
A406923 Novartis Pluvicto A5 Patient Booklet-d8.pdf
Reasons for updating
- Add New Doc
Updated on 29 April 2025
File name
Pluvicto_REG SPC_PF24-0060_IE MT clean_IPHA_April2024.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to restricted prescription (C)
Updated on 29 April 2025
File name
Pluvicto_REG PIL_PF24-0060_IE MT_April2024_clean_IPHA.pdf
Reasons for updating
- New PIL for new product
Novartis Ireland Limited

Address:
Vista Building, Elm Park Business Park, Merrion Road, Dublin 4, IrelandMedical Information E-mail:
medinfo.dublin@novartis.comTelephone:
+353 1 2601255Fax:
+353 1 2601263